Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | AKT1 | P31749 | 2/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | CDC25A | P30304 | 1/20 | 0.62 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5822144 | 0.92 | LMNA (0.74) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| SCHEMBL29060954 | 0.92 | LMNA (0.74) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| SCHEMBL22721395 | 0.92 | LMNA (0.74) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| SCHEMBL17817502 | 0.90 | CYP3A4 (0.57) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| SCHEMBL27641196 | 0.87 | LMNA (0.68) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| SCHEMBL3828412 | 0.87 | ADRA1A (0.48) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| Cetrimonium SCHEMBL28250740 | 0.86 | CYP3A4 (0.63) | CYP3A4LMNAAKT1ESR1ADORA3 | |
| SCHEMBL27895927 | 0.84 | CYP3A4 (1.00) | CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL1020179 | 0.84 | CYP3A4 (1.00) | CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL18570 | 0.84 | CYP3A4 (1.00) | CYP3A4TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12551441-B2 | Water soluble silicon-containing granulate | BIO MINERALS NV (BE) | 2026-02-17 | — | — | US | claimed |
| US-20240408130-A1 | Combination of Silicon and Magnesium for the Prevention and Treatment of Muscle Cramps | BIO MINERALS N.V. (BE) | 2024-12-12 | — | — | US | claimed |
| US-11878031-B2 | Silicic acids for use in the treatment of periodontitis | BIO MINERALS N.V. (BE) | 2024-01-23 | — | — | US | claimed |
| US-20220008454-A1 | Silicic Acids for Use in the Treatment of Periodontitis | BIO MINERALS N.V. (BE) | 2022-01-13 | — | — | US | claimed |
| CN-113226328-A | Silicic acid for treating periodontitis | 生物矿物股份有限公司 | 2021-08-06 | — | — | CN | claimed |
| WO-2020070300-A1 | SILICIC ACIDS FOR USE IN THE TREATMENT OF PERIODONTITIS | BIO MINERALS N.V. (BE) | 2020-04-09 | — | — | WO | claimed |
| EP-3632449-A1 | SILICIC ACIDS FOR USE IN THE TREATMENT OF PERIODONTITIS | Bio Minerals N.V. (BE) | 2020-04-08 | — | — | EP | claimed |
| US-12551441-B2 | Water soluble silicon-containing granulate | BIO MINERALS NV (BE) | 2026-02-17 | — | — | US | disclosed |
| US-20240408130-A1 | Combination of Silicon and Magnesium for the Prevention and Treatment of Muscle Cramps | BIO MINERALS N.V. (BE) | 2024-12-12 | — | — | US | disclosed |
| US-11878031-B2 | Silicic acids for use in the treatment of periodontitis | BIO MINERALS N.V. (BE) | 2024-01-23 | — | — | US | disclosed |
| US-20220143078-A1 | Combination of Silicon and Magnesium for the Prevention and Treatment of Muscle Cramps | BIO MINERALS N.V. (BE) | 2022-05-12 | — | — | US | disclosed |
| US-20220008454-A1 | Silicic Acids for Use in the Treatment of Periodontitis | BIO MINERALS N.V. (BE) | 2022-01-13 | — | — | US | disclosed |
| CN-113853202-A | Silicon-magnesium combination for preventing and treating muscle spasm | 生物矿物股份有限公司 | 2021-12-28 | — | — | CN | disclosed |
| EP-3650011-A1 | WATER SOLUBLE SILICON-CONTAINING GRANULATE | Bio Minerals NV (BE) | 2020-05-13 | — | — | EP | disclosed |
| WO-2020070300-A1 | SILICIC ACIDS FOR USE IN THE TREATMENT OF PERIODONTITIS | BIO MINERALS N.V. (BE) | 2020-04-09 | — | — | WO | disclosed |
| EP-3632449-A1 | SILICIC ACIDS FOR USE IN THE TREATMENT OF PERIODONTITIS | Bio Minerals N.V. (BE) | 2020-04-08 | — | — | EP | disclosed |
| US-9289381-B2 | Stabilization and storage of biological pharmaceutical compositions | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2016-03-22 | — | — | US | disclosed |
| US-20130089912-A1 | METHODS AND COMPOSITIONS FOR THE STABILIZATION OF BIOLOGIC MATERIAL | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE | 2013-04-11 | — | — | US | disclosed |
| US-20120230944-A1 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-09-13 | — | — | US | disclosed |
| WO-2011069037-A2 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2011-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551441-B2 | Water soluble silicon-containing granulate | SI, GIPR, VIP | CYP3A4 2169/4885LMNA 1265/4885AKT1 3666/4885 |
| US-20120230944-A1 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS | IL2, IL2RA, IL36G | CYP3A4 4089/4885LMNA 2050/4885AKT1 3510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.